Back
Monte Rosa Therapeutics Vs. Innodata Industry Stock Comparison
Buy
60
GLUE
Monte Rosa Therapeutics
Last Price:
$6.22
Seasonality Move:
-16.98%
Buy
51
INOD
Innodata
Last Price:
$43.15
Seasonality Move:
9.95%
Buy
60
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
-
The current Monte Rosa Therapeutics [GLUE] share price is $6.21. The Score for GLUE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GLUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $6.21The current trend is relatively stagnant and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
GLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 50.13 | Buy |
Chaikin Money Flow: | -285490 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.86 - 6.72) | Sell |
Bollinger Bands (100): | (5.67 - 8.63) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 44.5 | Sell |
Chaikin Money Flow: | -838391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.39 - 56.81) | Sell |
Bollinger Bands (100): | (28.15 - 49.55) | Buy |
GLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.14 | Buy |
20-day SMA: | 6.18 | Buy |
50-day SMA: | 6.26 | Sell |
200-day SMA: | 5.95 | Buy |
8-day EMA: | 6.21 | Buy |
20-day EMA: | 6.19 | Buy |
50-day EMA: | 6.42 | Sell |
200-day EMA: | 6.33 | Sell |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.61 | Sell |
20-day SMA: | 51.75 | Sell |
50-day SMA: | 44 | Sell |
200-day SMA: | 27.42 | Buy |
8-day EMA: | 47.25 | Sell |
20-day EMA: | 48.54 | Sell |
50-day EMA: | 44.99 | Sell |
200-day EMA: | 30.74 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.03 per share, and an increase next year of $0.36 per share.
Monte Rosa Therapeutics Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |